These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8241674)

  • 1. Serum concentrations of procollagen I C-terminal propeptide, osteocalcin and insulin-like growth factor-I in patients with non-lethal osteogenesis imperfecta.
    Brenner RE; Schiller B; Vetter U; Ittner J; Teller WM
    Acta Paediatr; 1993 Sep; 82(9):764-7. PubMed ID: 8241674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced serum levels of carboxy-terminal propeptide of human type I procollagen in a family with type I-A osteogenesis imperfecta.
    Minisola S; Piccioni AL; Rosso R; Romagnoli E; Pacitti MT; Scarnecchia L; Mazzuoli G
    Metabolism; 1994 Oct; 43(10):1261-5. PubMed ID: 7934978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collagen peptides in osteogenesis imperfecta, idiopathic juvenile osteoporosis and Ehlers--Danlos syndrome.
    Prószyńska K; Wieczorek E; Olszaniecka M; Lorenc RS
    Acta Paediatr; 1996 Jun; 85(6):688-91. PubMed ID: 8816205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone treatment in osteogenesis imperfecta with quantitative defect of type I collagen synthesis.
    Antoniazzi F; Bertoldo F; Mottes M; Valli M; Sirpresi S; Zamboni G; Valentini R; Tató L
    J Pediatr; 1996 Sep; 129(3):432-9. PubMed ID: 8804334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone formation markers in adults with mild osteogenesis imperfecta.
    Cundy T; Horne A; Bolland M; Gamble G; Davidson J
    Clin Chem; 2007 Jun; 53(6):1109-14. PubMed ID: 17434905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteogenesis imperfecta: bone turnover, bone density, and ultrasound parameters.
    Cepollaro C; Gonnelli S; Pondrelli C; Montagnani A; Martini S; Bruni D; Gennari C
    Calcif Tissue Int; 1999 Aug; 65(2):129-32. PubMed ID: 10430645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twenty-four-hour osteocalcin, carboxyterminal propeptide of type I procollagen, and aminoterminal propeptide of type III procollagen rhythms in normal and growth-retarded children.
    Saggese G; Baroncelli GI; Bertelloni S; Cinquanta L; DiNero G
    Pediatr Res; 1994 Apr; 35(4 Pt 1):409-15. PubMed ID: 8047377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive linear growth and bone responses to growth hormone treatment in children with types III and IV osteogenesis imperfecta: high predictive value of the carboxyterminal propeptide of type I procollagen.
    Marini JC; Hopkins E; Glorieux FH; Chrousos GP; Reynolds JC; Gundberg CM; Reing CM
    J Bone Miner Res; 2003 Feb; 18(2):237-43. PubMed ID: 12568401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type I and type III procollagen propeptides in amniotic fluid of normal pregnancies and in a case of mild osteogenesis imperfecta.
    Kauppila S; Tekay A; Risteli L; Koivisto M; Risteli J
    Eur J Clin Invest; 1998 Oct; 28(10):831-7. PubMed ID: 9792997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum osteocalcin and carboxyterminal propeptide of type I procollagen in rheumatoid arthritis.
    Kröger H; Risteli J; Risteli L; Penttilä I; Alhava E
    Ann Rheum Dis; 1993 May; 52(5):338-42. PubMed ID: 8323381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of type I procollagen C-terminal propeptide, insulin-like growth factor-I (IGF-I), and IGF binding protein-3 in obese children and adolescents: relationship to gender, pubertal development, growth, insulin, and nutritional status.
    Falorni A; Bini V; Cabiati G; Papi F; Arzano S; Celi F; Sanasi M
    Metabolism; 1997 Aug; 46(8):862-71. PubMed ID: 9258266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carboxy-terminal propeptide of human type I collagen and pyridinium cross-links as markers of bone growth in infants 1 to 18 months of age.
    Lieuw-A-Fa M; Sierra RI; Specker BL
    J Bone Miner Res; 1995 Jun; 10(6):849-53. PubMed ID: 7572307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum sclerostin levels are decreased in adult patients with different types of osteogenesis imperfecta.
    Kocijan R; Muschitz C; Fahrleitner-Pammer A; Amrein K; Pietschmann P; Haschka J; Dinu S; Kapiotis S; Resch H
    J Clin Endocrinol Metab; 2014 Feb; 99(2):E311-9. PubMed ID: 24203063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type I procollagen propeptide in patients on CAPD: its relationships with bone histology, osteocalcin, and parathyroid hormone.
    Joffe P; Heaf JG; Jensen LT
    Nephrol Dial Transplant; 1995 Oct; 10(10):1912-7. PubMed ID: 8592603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human insulin-like growth factor I, recombinant human growth hormone, and sex steroids: effects on markers of bone turnover in humans.
    Mauras N; Doi SQ; Shapiro JR
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2222-6. PubMed ID: 8964855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased serum concentrations of type I procollagen C-terminal propeptide and osteocalcin during a short course of calcitriol administration to adult male volunteers.
    Gram J; Bollerslev J; Nielsen HK; Junker P
    Acta Endocrinol (Copenh); 1991 Dec; 125(6):609-13. PubMed ID: 1789055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor axis, bone and collagen turnover in children with atopic dermatitis treated with topical glucocorticosteroids.
    Wolthers OD; Heuck C; Ternowitz T; Heickendorff L; Nielsen HK; Frystyk J
    Dermatology; 1996; 192(4):337-42. PubMed ID: 8864369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BPS804 Anti-Sclerostin Antibody in Adults With Moderate Osteogenesis Imperfecta: Results of a Randomized Phase 2a Trial.
    Glorieux FH; Devogelaer JP; Durigova M; Goemaere S; Hemsley S; Jakob F; Junker U; Ruckle J; Seefried L; Winkle PJ
    J Bone Miner Res; 2017 Jul; 32(7):1496-1504. PubMed ID: 28370407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum concentrations of the type I and III procollagen propeptides as biochemical markers of growth velocity in healthy infants and children and in children with growth disorders.
    Trivedi P; Risteli J; Risteli L; Hindmarsh PC; Brook CG; Mowat AP
    Pediatr Res; 1991 Sep; 30(3):276-80. PubMed ID: 1945568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased serum levels of carboxyterminal propeptide of type 1 collagen (PICP) in hyperthyroidism.
    Legovini P; De Menis E; Da Rin G; Roiter I; Breda F; Artuso V; Di Virgilio R; Conte N
    Horm Metab Res; 1994 Jul; 26(7):334-7. PubMed ID: 7959610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.